Jacobi Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,008
Closed -$226K 668
2026
Q1
$226K Buy
1,008
+52
+5% +$13K 0.01% 589
2025
Q4
$230K Sell
956
-10
-1% -$2.56K 0.01% 579
2025
Q3
$265K Buy
966
+183
+23% +$50K 0.02% 538
2025
Q2
$202K Sell
783
-465
-37% -$111K 0.01% 577
2025
Q1
$279K Buy
1,248
+124
+11% +$28.9K 0.02% 493
2024
Q4
$257K Buy
+1,124
New +$271K 0.02% 508
2021
Q4
Sell
-81
Closed -$21K 1120
2021
Q3
$21K Buy
81
+11
+16% +$3.01K ﹤0.01% 862
2021
Q2
$17K Sell
70
-25
-26% -$5.26K ﹤0.01% 887
2021
Q1
$18K Buy
95
+70
+280% +$14K ﹤0.01% 805
2020
Q4
$5K Hold
25
﹤0.01% 1015
2020
Q3
$4K Hold
25
﹤0.01% 996
2020
Q2
$5K Hold
25
﹤0.01% 919
2020
Q1
$4K Hold
25
﹤0.01% 869
2019
Q4
$4K Hold
25
﹤0.01% 881
2019
Q3
$3K Hold
25
﹤0.01% 905
2019
Q2
$3K Hold
25
﹤0.01% 896
2019
Q1
$3K Hold
25
﹤0.01% 857
2018
Q4
$3K Hold
25
﹤0.01% 821
2018
Q3
$3K Hold
25
﹤0.01% 860
2018
Q2
$3K Hold
25
﹤0.01% 891
2018
Q1
$2K Hold
25
﹤0.01% 901
2017
Q4
$2K Buy
+25
New +$2.06K ﹤0.01% 859

Other funds holding RMD

Jacobi Capital Management's RMD Position: Q2 2026 in Review

Jacobi Capital Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,008 shares — an estimated $226K sold.

Jacobi Capital Management first reported a position in RMD in Q4 2017 and held it in 22 quarters. The position peaked at $279K in Q1 2025. 319 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Jacobi Capital Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Jacobi Capital Management sold 1,008 ResMed shares in Q2 2026, an estimated $226K.
  • Jacobi Capital Management first reported a position in ResMed in Q4 2017 and held it in 22 quarters.
  • Jacobi Capital Management's ResMed position peaked at $279K in Q1 2025.
  • 319 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Jacobi Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.